Intrexon | XON - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Agenus USD 58.98M 12.1M 2026-06
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 2.86B 16.65B 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Heron Therapeutics USD 11.64M 2.67M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
MacroGenics USD 3.44M 845K 2026-06
MannKind USD 11.04M 5.1M 2026-06
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Veracyte USD 8.02M 1.12M 2026-06
Xencor USD 12.65M 4.73M 2026-06